Work

NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells

Year: 2018

Type: review

Source: Advanced Drug Delivery Reviews

DOI: 10.1016/j.addr.2018.03.006

Authors: Yu Jen Jan, Jie-Fu Chen, Yazhen Zhu, Yi-Tsung Lu, Szu Hao Chen, Howard Chung, Matthew Smalley, Yen-Wen Huang, Jiantong Dong, Li-Ching Chen, Hsiao-Hua Yu, James S. Tomlinson, Shuang Hou, Vatche G. Agopian, Edwin M. Posadas, Hsian-Rong Tseng

Institutions: Cedars-Sinai Medical Center, California NanoSystems Institute, University of California, Los Angeles, University of Southern California, USC Norris Comprehensive Cancer Center, CytoLumina Technologies (United States), Cathay General Hospital, Institute of Chemistry, Academia Sinica, VA Greater Los Angeles Healthcare System

Language: English

Topic: Microfluidic and Bio-sensing Technologies

Subfield: Biomedical Engineering

Field: Engineering

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cedars-Sinai Medical Center, National Institutes of Health, National Cancer Institute

Awards: A blood test to identify prostate cancer patients at risk for visceral metastasis, G2061683339, G2775455910, 3D-Nanostrcutured Substrates for Detection of Circulating Tumor Cells, G628664053, G6717269746, Advanced Development of An Integrated CTC Enrichment Technology, CTC Purification System Based on Thermoresponsive NanoSubstrates, G9000069030, G9000107426, G9000115021, G9000154689

OpenAlex ID: W2791040231

FWCI: 1.317

Cites: 121

Cited by: 113

Related to: 10